BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21452866)

  • 1. Time-resolved SAXS/WAXS study of the phase behavior and microstructural evolution of drug/PEG solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2011 Jun; 8(3):932-9. PubMed ID: 21452866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the microstructure of semicrystalline solid dispersions.
    Zhu Q; Taylor LS; Harris MT
    Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2012 Mar; 9(3):546-53. PubMed ID: 22299821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of monoPEGylated human galectin-2 by small-angle X-ray and neutron scattering: concentration dependence of PEG conformation in the conjugate.
    He L; Wang H; Garamus VM; Hanley T; Lensch M; Gabius HJ; Fee CJ; Middelberg A
    Biomacromolecules; 2010 Dec; 11(12):3504-10. PubMed ID: 21049922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
    Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact angle, WAXS, and SAXS analysis of poly(beta-hydroxybutyrate) and poly(ethylene glycol) block copolymers obtained via Azotobacter vinelandii UWD.
    Townsend KJ; Busse K; Kressler J; Scholz C
    Biotechnol Prog; 2005; 21(3):959-64. PubMed ID: 15932280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and modeling of the eutectic composition of various drug-polyethylene glycol solid dispersions.
    Baird JA; Taylor LS
    Pharm Dev Technol; 2011 Jun; 16(3):201-11. PubMed ID: 20141502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers.
    Chen Z; Liu Z; Qian F
    Mol Pharm; 2015 Feb; 12(2):590-9. PubMed ID: 25569586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends.
    Janssens S; Denivelle S; Rombaut P; Van den Mooter G
    Eur J Pharm Sci; 2008 Oct; 35(3):203-10. PubMed ID: 18656535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions.
    Zhu Q; Toth SJ; Simpson GJ; Hsu HY; Taylor LS; Harris MT
    J Phys Chem B; 2013 Feb; 117(5):1494-500. PubMed ID: 23320811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000.
    Cwiertnia B
    Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-living intermediates during a lamellar to a diamond-cubic lipid phase transition: a small-angle X-ray scattering investigation.
    Angelov B; Angelova A; Vainio U; Garamus VM; Lesieur S; Willumeit R; Couvreur P
    Langmuir; 2009 Apr; 25(6):3734-42. PubMed ID: 19708151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
    Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
    Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the PEG layer of sterically stabilized liposomes: a SAXS study.
    Varga Z; Wacha A; Vainio U; Gummel J; Bóta A
    Chem Phys Lipids; 2012 May; 165(4):387-92. PubMed ID: 22227108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene glycol)-conjugated phospholipids in aqueous micellar solutions: hydration, static structure, and interparticle interactions.
    Sato T; Sakai H; Sou K; Buchner R; Tsuchida E
    J Phys Chem B; 2007 Feb; 111(6):1393-401. PubMed ID: 17286354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media.
    Arleth L; Ashok B; Onyuksel H; Thiyagarajan P; Jacob J; Hjelm RP
    Langmuir; 2005 Apr; 21(8):3279-90. PubMed ID: 15807565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.